Find data for mouse strain: SEA/GnJ


Search SEA/GnJ data:


Click on pulldowns to see SEA/GnJ mean measured values with summary statistic tooltips.

Select table page: First Prev 1 - 10 / 12 (12) Next Last
Sort/
Pick
Data set
Procedure / Protocol
Treatment
Phenotype Measure / Variable (click to view)
Panel
No. of Strains
Sex
Age
Sample Size (Avg)
Year
    Wiltshire4 immune cell quantification BEZ235 B cells, percent viability   [%]  Bcells_BEZ   52401     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    Wiltshire4 immune cell quantification BEZ235 T cells, percent viability   [%]  Tcells_BEZ   52407     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    Wiltshire4 immune cell quantification BEZ235 monocytes, percent viability   [%]  monocytes_BEZ   52413     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    Wiltshire4 immune cell quantification doxorubicin B cells, percent viability   [%]  Bcells_Dox   52421     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification doxorubicin T cells, percent viability   [%]  Tcells_Dox   52427     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification doxorubicin monocytes, percent viability   [%]  monocytes_Dox   52433     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification idarubicin B cells, percent viability   [%]  Bcells_Ida   52441     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification idarubicin T cells, percent viability   [%]  Tcells_Ida   52447     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification idarubicin monocytes, percent viability   [%]  monocytes_Ida   52453     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 35 m 10wks N=4 2015
    Wiltshire4 immune cell quantification selumetinib B cells, percent viability   [%]  Bcells_Sel   52461     dose [µM]:    control    0.046    0.137    1.235    11.1    100 inbred w/CC7 34 m 10wks N=4 2015
    All boxes             To see more rows use the paging control at top.


Analysis Tools

  MEASURES (0/0)